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The   aim   of   our   study   was   to   unravel   the   mechanisms   underlying   the   vaccine-­induced  
immune   responses   by   native   and   recombinant   ASP-­based   vaccines   against   the  
gastrointestinal   parasite   Cooperia   oncophora.   Cattle   were   immunized   with   the   protective  
native  vaccine  and   the  antigen-­specific  humoral  and  cellular   responses  compared  with   the  
responses  induced  by  a  non-­protective  recombinantly  produced  version  of  the  vaccine.    
We   observed   that   in-­vitro   re-­stimulation   of   lymphocytes   from   calves   vaccinated   with   the  
native  C.  oncophora  vaccine  resulted  in  a  marked  proliferation  of  CD4-­T  cells  and  NK  cells  
systemically,  and  γδ-­T  cells,  CD4-­T  cells  and  NK  cells   in  the  local  draining  lymph  nodes  of  
the   small   intestine.  Although   the   recombinant   vaccine   induced  a   similar   type   of   response,  
the  magnitude  of  the  cellular  proliferation,  both  systemically  and  mucosally,  was  significantly  
lower  compared  to  the  native  vaccine.  In  terms  of  humoral  responses,  vaccination  with  both  
native   and   recombinant   vaccines   resulted   in   an   increase   of   ASP-­specific   IgG1   and   IgG2  
levels  in  serum  and  mucosa  when  compared  to  control  animals.  However,  inhibition  ELISAs  
showed  that  the  antibodies  induced  by  the  native  vaccine  markedly  differed  in  their  binding  
specificity   compared   to   the   antibodies   raised   against   the   non-­protective   recombinant  
vaccine.    
In   summary,   the   outcome   of   this   research   shows   that   a   protective   response   following  
vaccination  is  associated  with  a  strong  cellular  response,   in  particular  CD4-­T  cells,  and  the  
induction  of  antigen-­specific  IgG1  and  IgG2-­type  antibodies.  Whether  the  differences  in  the  
immune   responses   induced   are   caused   by   variations   in   the   conformational   state   of   the  
native  and  recombinant  version  of  the  ASP  antigen  is  currently  being  further  investigated.    
  
  
	  
